STAT+: Merck shares fall as sales of HPV vaccine drop in China

Shares of Merck fell 9% Tuesday after the company reported that in the second quarter, it saw a decrease in shipments of its HPV vaccine Gardasil in China, a significant market for the drug.

The company brought in $2.48 billion in sales of Gardasil in the second quarter, slightly lower than estimates of $2.5 billion made by analysts polled by Visible Alpha.

“The reductions during the second quarter was surprising, and I would point out was a meaningful departure from prior trends,” Merck’s CEO Rob Davis said.

Continue to STAT+ to read the full story…

Read Original Article: STAT+: Merck shares fall as sales of HPV vaccine drop in China »